Breaking News Instant updates and real-time market news.

CAIXY

CaixaBank

$0.00 /

+ (+0.00%)

05:19
11/25/20
11/25
05:19
11/25/20
05:19

CaixaBank downgraded to Hold from Buy at HSBC

HSBC analyst Domenico Santoro downgraded CaixaBank to Hold from Buy with a EUR 2.20 price target.

CAIXY CaixaBank
$0.00 /

+ (+0.00%)

11/20/20 Credit Suisse
CaixaBank price target raised to EUR 2.60 from EUR 2.50 at Credit Suisse
11/02/20 UBS
CaixaBank price target lowered to EUR 2.35 from EUR 2.40 at UBS
10/20/20 UBS
CaixaBank price target lowered to EUR 2.40 from EUR 2.55 at UBS
10/01/20 Oddo BHF
CaixaBank downgraded to Neutral from Buy at Oddo BHF

TODAY'S FREE FLY STORIES

Upgrade
News Corp. upgraded to Overweight from Neutral at JPMorgan » 04:52
01/27/21
01/27
04:52
01/27/21
04:52
NWSA

News Corp.

$19.14 /

+0.38 (+2.03%)

JPMorgan analyst Alexia…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NWSA News Corp.
$19.14 /

+0.38 (+2.03%)

NWSA News Corp.
$19.14 /

+0.38 (+2.03%)

07/21/20 JPMorgan
News Corp. upgraded to Neutral on valuation 'disconnect' at JPMorgan
07/21/20 JPMorgan
News Corp. upgraded to Neutral from Underweight at JPMorgan
06/12/20 Loop Capital
News Corp price target raised to $18 from $16 at Loop Capital
NWSA News Corp.
$19.14 /

+0.38 (+2.03%)

NWSA News Corp.
$19.14 /

+0.38 (+2.03%)

NWSA News Corp.
$19.14 /

+0.38 (+2.03%)

NWSA News Corp.
$19.14 /

+0.38 (+2.03%)

Downgrade
Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan » 04:52
01/27/21
01/27
04:52
01/27/21
04:52
VIR

Vir Biotechnology

$76.93 /

+32.59 (+73.50%)

JPMorgan analyst Anupam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIR Vir Biotechnology
$76.93 /

+32.59 (+73.50%)

VIR Vir Biotechnology
$76.93 /

+32.59 (+73.50%)

01/20/21 H.C. Wainwright
Vir Biotechnology price target raised to $125 from $100 at H.C. Wainwright
12/24/20 Baird
Baird maintains 'profound skepticism' of Vir's COVID antibody after Lilly data
10/07/20 Goldman Sachs
Goldman says Lilly comments support need for multiple COVID-19 antibody makers
10/07/20 H.C. Wainwright
Vir Biotechnology price target raised to $100 from $80 at H.C. Wainwright
VIR Vir Biotechnology
$76.93 /

+32.59 (+73.50%)

  • 08
    Jul
VIR Vir Biotechnology
$76.93 /

+32.59 (+73.50%)

VIR Vir Biotechnology
$76.93 /

+32.59 (+73.50%)

Upgrade
Frequency Therapeutics upgraded to Overweight from Neutral at JPMorgan » 04:51
01/27/21
01/27
04:51
01/27/21
04:51
FREQ

Frequency Therapeutics

$37.18 /

-0.6 (-1.59%)

JPMorgan analyst Anupam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FREQ Frequency Therapeutics
$37.18 /

-0.6 (-1.59%)

FREQ Frequency Therapeutics
$37.18 /

-0.6 (-1.59%)

12/22/20 B. Riley Securities
Frequency Therapeutics initiated with a Buy at B. Riley Securities
12/16/20 Oppenheimer
Frequency Therapeutics price target raised to $48 from $36 at Oppenheimer
07/13/20 Oppenheimer
Frequency Therapeutics initiated with an Outperform at Oppenheimer
05/18/20 JPMorgan
JPMorgan downgrades Frequency Therapeutics on unclear data timelines
FREQ Frequency Therapeutics
$37.18 /

-0.6 (-1.59%)

Downgrade
Pearson downgraded to Neutral from Overweight at JPMorgan » 04:50
01/27/21
01/27
04:50
01/27/21
04:50
PSO

Pearson

$10.48 /

+0.66 (+6.72%)

JPMorgan analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSO Pearson
$10.48 /

+0.66 (+6.72%)

PSO Pearson
$10.48 /

+0.66 (+6.72%)

01/21/21 Barclays
Pearson price target raised to 630 GBp from 520 GBp at Barclays
01/21/21 Exane BNP Paribas
Pearson downgraded to Neutral from Outperform at Exane BNP Paribas
01/12/21 Berenberg
Pearson price target raised to 475 GBp from 450 GBp at Berenberg
12/17/20 UBS
Pearson price target raised to 750 GBp from 650 GBp at UBS
PSO Pearson
$10.48 /

+0.66 (+6.72%)

Downgrade
Air France-KLM downgraded to Sell from Hold at Berenberg » 04:48
01/27/21
01/27
04:48
01/27/21
04:48
AFLYY

Air France-KLM

$0.00 /

+ (+0.00%)

Berenberg analyst Adrian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AFLYY Air France-KLM
$0.00 /

+ (+0.00%)

AFLYY Air France-KLM
$0.00 /

+ (+0.00%)

01/22/21 Kepler Cheuvreux
Air France-KLM downgraded to Reduce from Hold at Kepler Cheuvreux
01/20/21 Barclays
Air France-KLM price target raised to EUR 5.10 from EUR 2.70 at Barclays
12/04/20 Deutsche Bank
Air France-KLM price target raised to EUR 3.50 from EUR 2.10 at Deutsche Bank
12/01/20 UBS
Air France-KLM price target raised to EUR 4.45 from EUR 3.35 at UBS
AFLYY Air France-KLM
$0.00 /

+ (+0.00%)

AFLYY Air France-KLM
$0.00 /

+ (+0.00%)

Downgrade
Erste Group downgraded to Neutral from Outperform at Exane BNP Paribas » 04:47
01/27/21
01/27
04:47
01/27/21
04:47
EBKDY

Erste Group Bank

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EBKDY Erste Group Bank
$0.00 /

+ (+0.00%)

01/20/21 JPMorgan
Erste Group Bank price target raised to EUR 28 from EUR 25 at JPMorgan
01/11/21 UBS
Erste Group Bank price target raised to EUR 29 from EUR 23 at UBS
10/29/20 UBS
Erste Group Bank price target lowered to EUR 23 from EUR 24.80 at UBS
10/23/20 Societe Generale
Erste Group Bank price target lowered to EUR 25 from EUR 26 at Societe Generale
Downgrade
SGS SA downgraded to Hold from Buy at Berenberg » 04:47
01/27/21
01/27
04:47
01/27/21
04:47
SGSOY

SGS SA

$0.00 /

+ (+0.00%)

Berenberg analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGSOY SGS SA
$0.00 /

+ (+0.00%)

01/14/21 Deutsche Bank
SGS SA price target raised to CHF 2,640 from CHF 2,330 at Deutsche Bank
12/10/20 JPMorgan
SGS SA upgraded to Overweight from Neutral at JPMorgan
12/03/20 Morgan Stanley
SGS SA upgraded to Overweight from Equal Weight at Morgan Stanley
11/11/20 RBC Capital
SGS SA price target raised to CHF 2,700 from CHF 2,500 at RBC Capital
Upgrade
Intertek upgraded to Buy from Hold at Berenberg » 04:46
01/27/21
01/27
04:46
01/27/21
04:46
IKTSY

Intertek

$0.00 /

+ (+0.00%)

Berenberg analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IKTSY Intertek
$0.00 /

+ (+0.00%)

01/14/21 Deutsche Bank
Intertek price target raised to 5,800 GBp from 4,900 GBp at Deutsche Bank
01/13/21 HSBC
Intertek upgraded to Hold from Reduce at HSBC
12/08/20 BofA
Intertek upgraded to Buy from Underperform at BofA
12/07/20 Exane BNP Paribas
Intertek upgraded to Outperform from Neutral at Exane BNP Paribas
Downgrade
Babcock downgraded to Underweight from Overweight at Barclays » 04:43
01/27/21
01/27
04:43
01/27/21
04:43
BCKIF

Babcock

$0.00 /

+ (+0.00%)

Barclays analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCKIF Babcock
$0.00 /

+ (+0.00%)

01/08/21 JPMorgan
Babcock price target lowered to 335 GBp from 400 GBp at JPMorgan
01/04/21 Exane BNP Paribas
Babcock downgraded to Underperform from Neutral at Exane BNP Paribas
12/09/20 JPMorgan
Babcock price target lowered to 400 GBp from 405 GBp at JPMorgan
08/19/20 Morgan Stanley
Babcock initiated with an Equal Weight at Morgan Stanley
General news
FX Action: USD-CAD has recouped » 04:05
01/27/21
01/27
04:05
01/27/21
04:05

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The dollar and most currencies have remained in idling mode » 03:35
01/27/21
01/27
03:35
01/27/21
03:35

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FOMC Preview: » 01:55
01/27/21
01/27
01:55
01/27/21
01:55

FOMC Preview: No changes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Asian market Update: » 01:40
01/27/21
01/27
01:40
01/27/21
01:40

Asian market Update:…

Asian market Update: There wasn't a lot of movement in markets overnight, with traders clearly cautious ahead of the FOMC announcement today. Major indices are narrowly mixed. The ASX underperformed in catch up trade, while Nikkei and Hang Seng managed modest gains. NASDAQ futures are up 0.5% after positive earnings from Microsoft, but other U.S. futures are in the red. The Nikkei is currently up 0.3%, the Hang Seng 0.08%, while the CSI 300 is down -0.01% and the ASX -0.65%. Treasury yields are little changed, while in FX markets USD-JPY has lifted to 103.68. The front end WTI future meanwhile is trading at USD 52.98 per barrel.

General news
U.S. durable goods preview » 01:40
01/27/21
01/27
01:40
01/27/21
01:40

U.S. durable goods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Notable companies reporting before tomorrow's open » 20:25
01/26/21
01/26
20:25
01/26/21
20:25
T

AT&T

$29.71 /

+0.6 (+2.06%)

, ABT

Abbott

$114.73 /

+0.01 (+0.01%)

, BA

Boeing

$201.95 /

-1.48 (-0.73%)

, ANTM

Anthem

$312.51 /

-2.83 (-0.90%)

, BX

Blackstone

$65.07 /

+0.035 (+0.05%)

, ADP

ADP

$164.48 /

+0.93 (+0.57%)

, PGR

Progressive

$91.63 /

-0.91 (-0.98%)

, GD

General Dynamics

$150.29 /

-2.95 (-1.93%)

, APH

Amphenol

$130.06 /

-2.7 (-2.03%)

, VFC

VF Corp.

$85.18 /

+0.35 (+0.41%)

, GLW

Corning

$37.18 /

-1.28 (-3.33%)

, TXT

Textron

$49.70 /

-0.295 (-0.59%)

, KNX

Knight-Swift

$44.53 /

-0.51 (-1.13%)

, NYCB

New York Community Bancorp

$10.96 /

-0.07 (-0.63%)

, EAT

Brinker

$62.51 /

-1.63 (-2.54%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include AT&T (T), consensus 73c... Abbott (ABT), consensus $1.35... Boeing (BA), consensus ($1.80)... Anthem (ANTM), consensus $2.52... Blackstone (BX), consensus 88c... ADP (ADP), consensus $1.29... Progressive (PGR), consensus $1.66... General Dynamics (GD), consensus $3.54... Amphenol (APH), consensus $1.02... V.F. Corp. (VFC), consensus 90c... Corning (GLW), consensus 48c... Textron (TXT), consensus 91c... Knight-Swift (KNX), consensus 91c... New York Community Bancorp (NYCB), consensus 26c... Brinker International (EAT), consensus 33c.

ShowHide Related Items >><<
VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

TXT Textron
$49.70 /

-0.295 (-0.59%)

T AT&T
$29.71 /

+0.6 (+2.06%)

NYCB New York Community Bancorp
$10.96 /

-0.07 (-0.63%)

KNX Knight-Swift
$44.53 /

-0.51 (-1.13%)

GLW Corning
$37.18 /

-1.28 (-3.33%)

GD General Dynamics
$150.29 /

-2.95 (-1.93%)

EAT Brinker
$62.51 /

-1.63 (-2.54%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

BA Boeing
$201.95 /

-1.48 (-0.73%)

APH Amphenol
$130.06 /

-2.7 (-2.03%)

ANTM Anthem
$312.51 /

-2.83 (-0.90%)

ADP ADP
$164.48 /

+0.93 (+0.57%)

ABT Abbott
$114.73 /

+0.01 (+0.01%)

T AT&T
$29.71 /

+0.6 (+2.06%)

01/04/21
Fly Intel: Top five analyst upgrades
01/04/21 Raymond James
AT&T upgraded to Outperform from Market Perform at Raymond James
01/04/21 Raymond James
AT&T upgraded to Outperform from Market Perform at Raymond James
12/24/20 Raymond James
AT&T estimates lowered ahead of Q4 report at Raymond James
ABT Abbott
$114.73 /

+0.01 (+0.01%)

01/22/21 JPMorgan
JPMorgan confident Abbott results will beat Q4 estimates
12/10/20 Stifel
DexCom has 'significantly more' growth still to come, says Stifel
11/20/20 Piper Sandler
DexCom secured national reimbursement in France, says Piper Sandler
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
BA Boeing
$201.95 /

-1.48 (-0.73%)

01/20/21
Fly Intel: Top five analyst upgrades
01/20/21 Berenberg
Boeing upgraded to Hold from Sell at Berenberg
01/04/21
Fly Intel: Top five analyst downgrades
01/04/21 Baird
Boeing elevated to Fresh Pick at Baird
ANTM Anthem
$312.51 /

-2.83 (-0.90%)

01/26/21 Cowen
Anthem price target raised to $360 from $330 at Cowen
01/15/21 Jefferies
Anthem upgraded to Buy on more constructive commercial outlook at Jefferies
01/15/21 Jefferies
Anthem upgraded to Buy from Hold at Jefferies
01/13/21 Argus
Anthem price target raised to $380 from $300 at Argus
BX Blackstone
$65.07 /

+0.035 (+0.05%)

01/14/21
Fly Intel: Top five analyst initiations
01/14/21 Piper Sandler
Blackstone initiated with an Overweight at Piper Sandler
10/29/20 Oppenheimer
Blackstone upgraded to Outperform at Oppenheimer
10/29/20 Oppenheimer
Blackstone upgraded to Outperform from Perform at Oppenheimer
ADP ADP
$164.48 /

+0.93 (+0.57%)

01/12/21 Evercore ISI
ADP downgraded to Underperform from Outperform at Evercore ISI
12/18/20 Wells Fargo
ADP resumed with an Overweight at Wells Fargo
11/09/20 Credit Suisse
ADP price target raised to $190 from $185 at Credit Suisse
11/02/20 Barclays
ADP price target raised to $180 from $145 at Barclays
PGR Progressive
$91.63 /

-0.91 (-0.98%)

01/13/21 Gordon Haskett
Allstate lowering auto rates by 5% in several states, says Gordon Haskett
01/08/21 Goldman Sachs
Progressive downgraded to Sell from Neutral at Goldman Sachs
01/07/21 B. Riley Securities
Progressive price target raised to $96 from $88 at B. Riley Securities
01/04/21 Wells Fargo
Progressive downgraded to Underweight from Equal Weight at Wells Fargo
GD General Dynamics
$150.29 /

-2.95 (-1.93%)

11/03/20 Morgan Stanley
Morgan Stanley sees attractive buying opportunity in Defense stocks
10/29/20 Credit Suisse
General Dynamics price target lowered to $140 from $156 at Credit Suisse
10/02/20
Fly Intel: Top five analyst downgrades
10/02/20 Baird
Baird downgrades General Dynamics, sees no 'material' Gulfstream ramp
APH Amphenol
$130.06 /

-2.7 (-2.03%)

01/19/21 Baird
Baird incrementally positive on ITW's MTS test & simulation business acquisition
12/29/20 JPMorgan
Amphenol reinstated with a Neutral at JPMorgan
10/19/20 Baird
Amphenol initiated with an Outperform at Baird
09/15/20 UBS
Amphenol initiated with a Buy at UBS
VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

01/25/21 Cowen
VF Corp. price target raised to $99 from $91 at Cowen
01/25/21 Pivotal Research
VF Corp. price target raised to $86 from $76 at Pivotal Research
01/22/21 Williams Capital
VF Corp. initiated with a Buy at Williams Trading
01/21/21 Deutsche Bank
VF Corp. upgraded to Buy from Hold at Deutsche Bank
GLW Corning
$37.18 /

-1.28 (-3.33%)

01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
01/06/21
Fly Intel: Top five analyst initiations
01/06/21 UBS
Corning initiated with a Buy at UBS
TXT Textron
$49.70 /

-0.295 (-0.59%)

01/07/21 Baird
Textron downgraded to Neutral from Outperform at Baird
11/17/20 Susquehanna
Textron upgraded to Positive from Neutral at Susquehanna
11/17/20 Susquehanna
Textron upgraded to Positive from Neutral at Susquehanna
10/01/20 Cowen
Textron downgraded to Market Perform from Outperform at Cowen
KNX Knight-Swift
$44.53 /

-0.51 (-1.13%)

01/14/21 Citi
Knight-Swift price target raised to $48 from $46 at Citi
01/07/21 Wolfe Research
Knight-Swift downgraded to Peer Perform from Outperform at Wolfe Research
12/04/20
Evercore starts trucking coverage with preference for Old Dominion, Saia
12/04/20 Evercore ISI
Knight-Swift initiated with an In Line at Evercore ISI
NYCB New York Community Bancorp
$10.96 /

-0.07 (-0.63%)

01/15/21 Compass Point
New York Community Bancorp upgraded to Buy from Neutral at Compass Point
11/06/20 Morgan Stanley
New York Community Bancorp upgraded to Equal Weight at Morgan Stanley
11/06/20 Morgan Stanley
New York Community upgraded to Equal Weight from Underweight at Morgan Stanley
04/14/20 Compass Point
New York Community Bancorp initiated with a Neutral at Compass Point
EAT Brinker
$62.51 /

-1.63 (-2.54%)

01/25/21 Loop Capital
Brinker price target raised to $75 from $61 at Loop Capital
01/21/21 Piper Sandler
Brinker price target raised to $70 from $61 at Piper Sandler
01/19/21 Goldman Sachs
Brinker initiated with a Buy at Goldman Sachs
01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

TXT Textron
$49.70 /

-0.295 (-0.59%)

T AT&T
$29.71 /

+0.6 (+2.06%)

PGR Progressive
$91.63 /

-0.91 (-0.98%)

NYCB New York Community Bancorp
$10.96 /

-0.07 (-0.63%)

KNX Knight-Swift
$44.53 /

-0.51 (-1.13%)

GLW Corning
$37.18 /

-1.28 (-3.33%)

GD General Dynamics
$150.29 /

-2.95 (-1.93%)

EAT Brinker
$62.51 /

-1.63 (-2.54%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

BA Boeing
$201.95 /

-1.48 (-0.73%)

APH Amphenol
$130.06 /

-2.7 (-2.03%)

ANTM Anthem
$312.51 /

-2.83 (-0.90%)

ADP ADP
$164.48 /

+0.93 (+0.57%)

ABT Abbott
$114.73 /

+0.01 (+0.01%)

  • 07
    May
VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

T AT&T
$29.71 /

+0.6 (+2.06%)

GD General Dynamics
$150.29 /

-2.95 (-1.93%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

BA Boeing
$201.95 /

-1.48 (-0.73%)

ANTM Anthem
$312.51 /

-2.83 (-0.90%)

ABT Abbott
$114.73 /

+0.01 (+0.01%)

VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

TXT Textron
$49.70 /

-0.295 (-0.59%)

T AT&T
$29.71 /

+0.6 (+2.06%)

PGR Progressive
$91.63 /

-0.91 (-0.98%)

GLW Corning
$37.18 /

-1.28 (-3.33%)

GD General Dynamics
$150.29 /

-2.95 (-1.93%)

EAT Brinker
$62.51 /

-1.63 (-2.54%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

BA Boeing
$201.95 /

-1.48 (-0.73%)

ANTM Anthem
$312.51 /

-2.83 (-0.90%)

ADP ADP
$164.48 /

+0.93 (+0.57%)

ABT Abbott
$114.73 /

+0.01 (+0.01%)

TXT Textron
$49.70 /

-0.295 (-0.59%)

T AT&T
$29.71 /

+0.6 (+2.06%)

KNX Knight-Swift
$44.53 /

-0.51 (-1.13%)

GLW Corning
$37.18 /

-1.28 (-3.33%)

EAT Brinker
$62.51 /

-1.63 (-2.54%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

BA Boeing
$201.95 /

-1.48 (-0.73%)

ANTM Anthem
$312.51 /

-2.83 (-0.90%)

ADP ADP
$164.48 /

+0.93 (+0.57%)

ABT Abbott
$114.73 /

+0.01 (+0.01%)

Recommendations
Agios' Mitapivat on track as first approved therapy in PKD patients, says Piper » 20:13
01/26/21
01/26
20:13
01/26/21
20:13
AGIO

Agios Pharmaceuticals

$48.08 /

-1.45 (-2.93%)

Piper Sandler analyst…

Piper Sandler analyst Tyler Van Buren keeps his Overweight rating and $80 price target on Agios Pharmaceuticals after the company announced that its ACTIVATE-T trial of mitapivat in regularly transfused adults with PK deficiency demonstrated a statistically significant and clinically meaningful reduction in transfusion burden. Mitapivat is on track to become the first approved therapy for PKD patients, with Agios anticipating a filing for regulatory approval in the U.S. in Q2 of this year, which could lead to two potential 2022 launches, the analyst tells investors in a research note.

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$48.08 /

-1.45 (-2.93%)

AGIO Agios Pharmaceuticals
$48.08 /

-1.45 (-2.93%)

01/14/21 Barclays
Agios Pharmaceuticals price target raised to $58 from $50 at Barclays
12/23/20 Citi
Agios shares 'significantly undervalued at this point,' says Citi
12/22/20 SVB Leerink
Agios Pharmaceuticals price target lowered to $51 from $61 at SVB Leerink
12/22/20 Cantor Fitzgerald
Agios oncology deal a positive read to FT-4202 strategy, says Cantor Fitzgerald
AGIO Agios Pharmaceuticals
$48.08 /

-1.45 (-2.93%)

Downgrade
Visa downgraded to Sector Weight from Overweight at KeyBanc » 20:06
01/26/21
01/26
20:06
01/26/21
20:06
V

Visa

$202.01 /

+1.03 (+0.51%)

KeyBanc analyst Josh Beck…

KeyBanc analyst Josh Beck downgraded Visa to Sector Weight from Overweight with a $210 price target.

ShowHide Related Items >><<
V Visa
$202.01 /

+1.03 (+0.51%)

V Visa
$202.01 /

+1.03 (+0.51%)

01/26/21 Bernstein
Visa reinstated with an Outperform at Bernstein
01/14/21 Deutsche Bank
Visa price target raised to $270 from $220 at Deutsche Bank
01/13/21
Fly Intel: Top five analyst upgrades
01/13/21 KeyBanc
Visa price target raised to $225 from $210 at KeyBanc
V Visa
$202.01 /

+1.03 (+0.51%)

  • 13
    Oct
V Visa
$202.01 /

+1.03 (+0.51%)

V Visa
$202.01 /

+1.03 (+0.51%)

V Visa
$202.01 /

+1.03 (+0.51%)

Downgrade
MasterCard downgraded to Sector Weight from Overweight at KeyBanc » 20:05
01/26/21
01/26
20:05
01/26/21
20:05
MA

MasterCard

$327.71 /

-1.565 (-0.48%)

KeyBanc analyst Josh Beck…

KeyBanc analyst Josh Beck downgraded MasterCard to Sector Weight from Overweight with a $345 price target.

ShowHide Related Items >><<
MA MasterCard
$327.71 /

-1.565 (-0.48%)

MA MasterCard
$327.71 /

-1.565 (-0.48%)

01/25/21 Barclays
MasterCard price target raised to $380 from $360 at Barclays
01/14/21 Deutsche Bank
MasterCard price target raised to $420 from $383 at Deutsche Bank
01/13/21
Fly Intel: Top five analyst upgrades
01/13/21 Jefferies
Jefferies upgrades 'high-quality recovery play' MasterCard to Buy
MA MasterCard
$327.71 /

-1.565 (-0.48%)

MA MasterCard
$327.71 /

-1.565 (-0.48%)

MA MasterCard
$327.71 /

-1.565 (-0.48%)

MA MasterCard
$327.71 /

-1.565 (-0.48%)

Hot Stocks
Guardant Health CEO sells 160.9K shares of common stock » 19:40
01/26/21
01/26
19:40
01/26/21
19:40
GH

Guardant Health

$149.95 /

-7.27 (-4.62%)

In a regulatory filing,…

In a regulatory filing, Guardant Health disclosed that its CEO Helmy Eltoukhy sold 160.9K shares of common stock on January 22nd in a total transaction size of $25.6M, reducing his stake by about 5%.

ShowHide Related Items >><<
GH Guardant Health
$149.95 /

-7.27 (-4.62%)

GH Guardant Health
$149.95 /

-7.27 (-4.62%)

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
01/14/21 Canaccord
Natera price target raised to $125 from $112 at Canaccord
01/12/21 Canaccord
Guardant Health price target raised to $170 from $145 at Canaccord
01/11/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$149.95 /

-7.27 (-4.62%)

  • 07
    Oct
  • 02
    Jun
GH Guardant Health
$149.95 /

-7.27 (-4.62%)

Hot Stocks
BioXcel Therapeutics granted FDA Orphan Drug Designation for Talabostat » 19:30
01/26/21
01/26
19:30
01/26/21
19:30
BTAI

BioXcel Therapeutics

$51.39 /

+1.52 (+3.05%)

BioXcel Therapeutics…

BioXcel Therapeutics announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for Talabostat for the treatment of soft tissue sarcoma. Reference Link

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$51.39 /

+1.52 (+3.05%)

BTAI BioXcel Therapeutics
$51.39 /

+1.52 (+3.05%)

01/06/21 H.C. Wainwright
BioXcel Therapeutics price target raised to $185 from $175 at H.C. Wainwright
10/30/20
Fly Intel: Top five analyst initiations
10/30/20 Goldman Sachs
BioXcel Therapeutics initiated with a Buy at Goldman Sachs
09/02/20 Jefferies
BioXcel Therapeutics initiated with a Buy at Jefferies
BTAI BioXcel Therapeutics
$51.39 /

+1.52 (+3.05%)

  • 29
    Jul
  • 20
    Feb
BTAI BioXcel Therapeutics
$51.39 /

+1.52 (+3.05%)

Initiation
Berkeley Lights initiated with a Buy at Stifel » 19:27
01/26/21
01/26
19:27
01/26/21
19:27
BLI

Berkeley Lights

$73.07 /

-6.93 (-8.66%)

Stifel analyst Daniel…

Stifel analyst Daniel Arias initiated coverage of Berkeley Lights with a Buy rating and $105 price target.

ShowHide Related Items >><<
BLI Berkeley Lights
$73.07 /

-6.93 (-8.66%)

BLI Berkeley Lights
$73.07 /

-6.93 (-8.66%)

11/13/20 JPMorgan
Berkeley Lights price target raised to $100 from $75 at JPMorgan
11/09/20 KeyBanc
Berkeley Lights initiated with an Overweight at KeyBanc
08/11/20
Fly Intel: Top five analyst initiations
08/11/20 JPMorgan
JPMorgan starts 'industry pioneer' Berkeley Lights at Overweight
BLI Berkeley Lights
$73.07 /

-6.93 (-8.66%)

  • 19
    Nov
  • 17
    Jul
BLI Berkeley Lights
$73.07 /

-6.93 (-8.66%)

Hot Stocks
Sorrento Therapeutics jumps 5% to $11 after positive COVI-MSC study data  19:20
01/26/21
01/26
19:20
01/26/21
19:20
SRNE

Sorrento Therapeutics

$10.40 /

+1.11 (+11.95%)

 
ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$10.40 /

+1.11 (+11.95%)

SRNE Sorrento Therapeutics
$10.40 /

+1.11 (+11.95%)

01/21/21 Alliance Global Partners
Sorrento Therapeutics initiated with a Buy at Alliance Global Partners
07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
SRNE Sorrento Therapeutics
$10.40 /

+1.11 (+11.95%)

SRNE Sorrento Therapeutics
$10.40 /

+1.11 (+11.95%)

Hot Stocks
Rush Street Interactive to launch BetRivers.com online sportsbook in Virginia » 19:19
01/26/21
01/26
19:19
01/26/21
19:19
RSI

Rush Street Interactive

$21.01 /

-0.85 (-3.89%)

Rush Street Interactive…

Rush Street Interactive announced the launch of its flagship brand and industry leading online sportsbook, BetRivers.com, in Virginia. Beginning tomorrow, sports enthusiasts across the Commonwealth of Virginia will be able to register, deposit funds and place bets at BetRivers.com on their favorite teams and events safely from their mobile devices and computers.

ShowHide Related Items >><<
RSI Rush Street Interactive
$21.01 /

-0.85 (-3.89%)

RSI Rush Street Interactive
$21.01 /

-0.85 (-3.89%)

01/26/21
Fly Intel: Top five analyst initiations
01/26/21 Goldman Sachs
Rush Street Interactive initiated with a Neutral at Goldman Sachs
01/22/21
Fly Intel: Top five analyst initiations
01/22/21 Needham
Rush Street Interactive initiated with a Buy at Needham
RSI Rush Street Interactive
$21.01 /

-0.85 (-3.89%)

RSI Rush Street Interactive
$21.01 /

-0.85 (-3.89%)

RSI Rush Street Interactive
$21.01 /

-0.85 (-3.89%)

Hot Stocks
Sorrento reports 'positive' preliminary results of Phase 1b COVID-MSC study » 19:11
01/26/21
01/26
19:11
01/26/21
19:11
SRNE

Sorrento Therapeutics

$10.40 /

+1.11 (+11.95%)

Sorrento Therapeutics…

Sorrento Therapeutics announced positive preliminary results from its Phase 1b study of human allogeneic adipose-derived mesenchymal stem cells for patients suffering from COVID-19-induced acute respiratory distress or acute respiratory distress syndrome. This ongoing study iss a single arm, non-randomized Phase 1b study of the safety and preliminary efficacy of COVI-MSCs administered every other day for three infusions for a total of 1 x 106 cells/kg. The primary objective is to evaluate the safety of intravenous infusion of allogeneic adipose MSC cells in patients with COVID-19-induced ARD or ARDS. The secondary objective is to evaluate efficacy outcome variables to give guidance regarding the risk/benefit ratio in patients with COVID-19 respiratory distress. The first three patients enrolled tolerated treatment well and improved rapidly. Each of the three patients was discharged from the hospital within a week of starting the patient's COVI-MSC infusions and two patients were discharged on the day of their last infusion. One of the patients had been in the hospital for three weeks, unable to be weaned from significant oxygen support, and another patient with uncontrolled diabetes had been discharged previously but had to be readmitted due to recurrent ARD. Each of the infusions were well-tolerated and no patient reported any infusion-related adverse events. A fourth patient is currently at the beginning of a course of treatment, with no safety issues following the patient's first infusion. Additional enrollment continues.

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$10.40 /

+1.11 (+11.95%)

SRNE Sorrento Therapeutics
$10.40 /

+1.11 (+11.95%)

01/21/21 Alliance Global Partners
Sorrento Therapeutics initiated with a Buy at Alliance Global Partners
07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
SRNE Sorrento Therapeutics
$10.40 /

+1.11 (+11.95%)

SRNE Sorrento Therapeutics
$10.40 /

+1.11 (+11.95%)

Hot Stocks
Target, Levi Strauss expand partnership with limited-edition collection » 19:06
01/26/21
01/26
19:06
01/26/21
19:06
TGT

Target

$187.74 /

-2.33 (-1.23%)

, LEVI

Levi Strauss

$21.35 /

+0.13 (+0.61%)

Target Corporation (TGT)…

Target Corporation (TGT) announced a limited-edition collection with Levi Strauss & Co. (LEVI), featuring an assortment of home and lifestyle items and marking Levi's first Home partnership. Reinventing what a retailer's relationship with a national brand can represent, the Levi's for Target limited-edition Home collection builds on the decade-long partnership between the two iconic companies, which began with the introduction of the DENIZEN from Levi's value denim brand, and expanded in 2019 with the introduction of Levi's Red Tab brand at Target. As part of the Red Tab expansion, Target is rolling out curated in-store displays to be set in 500 stores by Fall 2021. The new Levi's for Target limited-edition collection launches Feb. 28, 2021. Available at Target.com and in most Target stores, the collection features thoughtfully-designed, durable pieces meant to inspire a more sustainable home and life.

ShowHide Related Items >><<
TGT Target
$187.74 /

-2.33 (-1.23%)

LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

TGT Target
$187.74 /

-2.33 (-1.23%)

01/14/21 DA Davidson
Target price target raised to $229 from $208 at DA Davidson
01/14/21 Cowen
Target price target raised to $230 from $190 at Cowen
01/14/21 Deutsche Bank
Target price target raised to $211 from $194 at Deutsche Bank
01/13/21 KeyBanc
Target price target raised to $235 from $180 at KeyBanc
LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

01/07/21 JPMorgan
Levi Strauss price target raised to $21 from $18 at JPMorgan
12/30/20 Guggenheim
Levi Strauss price target raised to $24 from $20 at Guggenheim
12/10/20
Fly Intel: Top five analyst upgrades
12/10/20 Goldman Sachs
Levi Strauss upgraded to Buy from Sell at Goldman Sachs
TGT Target
$187.74 /

-2.33 (-1.23%)

LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

TGT Target
$187.74 /

-2.33 (-1.23%)

TGT Target
$187.74 /

-2.33 (-1.23%)

LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

TGT Target
$187.74 /

-2.33 (-1.23%)

LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.